Renaissance Technologies
USNA icon

Renaissance Technologies’s Usana Health Sciences USNA Stock Holding History

Renaissance Technologies’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.8M Sell
1,017,630
-129,693
-11% -$2.57M 0.03% 705
2025
Q4 		$22.5M Buy
1,147,323
+21,793
+2% +$452K 0.03% 553
2025
Q3 		$31M Sell
1,125,530
-29,300
-3% -$902K 0.04% 538
2025
Q2 		$35.3M Buy
1,154,830
+69,566
+6% +$1.98M 0.05% 462
2025
Q1 		$29.3M Sell
1,085,264
-5,600
-0.5% -$177K 0.04% 506
2024
Q4 		$39.2M Sell
1,090,864
-58,400
-5% -$2.18M 0.06% 406
2024
Q3 		$43.6M Sell
1,149,264
-29,899
-3% -$1.23M 0.07% 368
2024
Q2 		$53.3M Sell
1,179,163
-43,200
-4% -$1.99M 0.09% 266
2024
Q1 		$59.3M Buy
1,222,363
+23,666
+2% +$1.16M 0.09% 269
2023
Q4 		$64.3M Sell
1,198,697
-9,300
-0.8% -$470K 0.1% 244
2023
Q3 		$70.8M Sell
1,207,997
-1,300
-0.1% -$81.3K 0.12% 177
2023
Q2 		$76.2M Sell
1,209,297
-2,500
-0.2% -$159K 0.11% 207
2023
Q1 		$76.2M Sell
1,211,797
-13,200
-1% -$788K 0.1% 236
2022
Q4 		$65.2M Sell
1,224,997
-82,800
-6% -$4.49M 0.09% 255
2022
Q3 		$73.3M Sell
1,307,797
-124,000
-9% -$8.2M 0.1% 231
2022
Q2 		$104M Buy
1,431,797
+7,534
+0.5% +$561K 0.12% 187
2022
Q1 		$113M Sell
1,424,263
-31,834
-2% -$2.87M 0.13% 158
2021
Q4 		$147M Sell
1,456,097
-62,603
-4% -$6.24M 0.18% 106
2021
Q3 		$140M Sell
1,518,700
-26,700
-2% -$2.57M 0.18% 113
2021
Q2 		$158M Sell
1,545,400
-22,600
-1% -$2.27M 0.2% 82
2021
Q1 		$153M Sell
1,568,000
-154,966
-9% -$14.1M 0.19% 98
2020
Q4 		$133M Sell
1,722,966
-71,900
-4% -$5.56M 0.14% 138
2020
Q3 		$132M Buy
1,794,866
+26,200
+1% +$2.1M 0.13% 146
2020
Q2 		$130M Buy
1,768,666
+186,966
+12% +$14.7M 0.11% 181
2020
Q1 		$91.4M Sell
1,581,700
-44,200
-3% -$3.07M 0.09% 227
2019
Q4 		$128M Sell
1,625,900
-33,200
-2% -$2.45M 0.1% 220
2019
Q3 		$113M Sell
1,659,100
-129,300
-7% -$8.68M 0.1% 242
2019
Q2 		$142M Sell
1,788,400
-118,966
-6% -$9.43M 0.13% 173
2019
Q1 		$160M Buy
1,907,366
+25,692
+1% +$2.68M 0.15% 153
2018
Q4 		$222M Sell
1,881,674
-217,492
-10% -$25.1M 0.24% 78
2018
Q3 		$253M Sell
2,099,166
-6,300
-0.3% -$782K 0.26% 67
2018
Q2 		$243M Buy
2,105,466
+144,000
+7% +$15.8M 0.26% 61
2018
Q1 		$168M Buy
1,961,466
+30,500
+2% +$2.36M 0.18% 101
2017
Q4 		$143M Buy
1,930,966
+12,700
+0.7% +$849K 0.16% 128
2017
Q3 		$111M Sell
1,918,266
-30,000
-2% -$1.77M 0.13% 169
2017
Q2 		$125M Buy
1,948,266
+186,600
+11% +$11.5M 0.16% 125
2017
Q1 		$101M Buy
1,761,666
+128,766
+8% +$7.69M 0.14% 144
2016
Q4 		$99.9M Buy
1,632,900
+33,734
+2% +$2.2M 0.16% 115
2016
Q3 		$111M Buy
1,599,166
+29,400
+2% +$1.94M 0.2% 89
2016
Q2 		$87.5M Buy
1,569,766
+115,366
+8% +$6.96M 0.17% 98
2016
Q1 		$88.3M Sell
1,454,400
-93,966
-6% -$5.53M 0.17% 102
2015
Q4 		$98.9M Sell
1,548,366
-125,400
-7% -$8.13M 0.22% 66
2015
Q3 		$112M Buy
1,673,766
+144,200
+9% +$10.2M 0.27% 50
2015
Q2 		$105M Sell
1,529,566
-113,600
-7% -$7.21M 0.24% 61
2015
Q1 		$91.3M Buy
1,643,166
+47,400
+3% +$2.43M 0.19% 90
2014
Q4 		$81.9M Buy
1,595,766
+194,966
+14% +$9.57M 0.2% 84
2014
Q3 		$51.6M Buy
1,400,800
+49,000
+4% +$1.77M 0.14% 145
2014
Q2 		$52.8M Buy
1,351,800
+42,834
+3% +$1.59M 0.12% 180
2014
Q1 		$49.3M Buy
1,308,966
+146,566
+13% +$5.12M 0.12% 176
2013
Q4 		$43.9M Buy
1,162,400
+142,200
+14% +$5.44M 0.11% 211
2013
Q3 		$44.3M Buy
1,020,200
+160,600
+19% +$6.45M 0.11% 200
2013
Q2 		$31.1M Buy
+859,600
New +$26.1M 0.08% 296

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies's USNA Position: Q1 2026 in Review

Renaissance Technologies reduced its Usana Health Sciences (USNA) stake by 11% in Q1 2026, selling an estimated $2.57M and leaving 1,017,630 shares worth $17.8M. The position accounts for 0.03% of the portfolio, ranked #705.

Renaissance Technologies first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $253M in Q3 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Renaissance Technologies held 1,017,630 shares of Usana Health Sciences worth $17.8M as of Q1 2026.
  • Renaissance Technologies sold 129,693 Usana Health Sciences shares in Q1 2026, an estimated $2.57M.
  • Usana Health Sciences made up 0.03% of Renaissance Technologies's portfolio in Q1 2026, its #705 holding.
  • Renaissance Technologies first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
  • Renaissance Technologies's Usana Health Sciences position peaked at $253M in Q3 2018.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.